Tesofensine

特索芬辛

Report date: 2026/03/23 20:03:44
NME

Base Information

Drug NameTesofensine
Drug Alias NameTesofensinumTesofensinaNS-2330
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin transporter inhibitorsDopamine transporter antagonistsNorepinephrine transporter inhibitors
TargetsNorepinephrine transporterDopamine transporterSerotonin transporter
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2Prader-Willi Syndrome +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[11] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNeurosearch AsSaniona A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeurosearch AsC.H. Boehringer Sohn Ag & Co. KgSaniona A/S +[4] 
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2Prader-Willi Syndrome +[5] 

Other Information

ATC CodeN/A
Related LinksWikipedia